# 18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma

> **NCT05096234** · PHASE1 · TERMINATED · sponsor: **Stanford University** · enrollment: 2 (actual)

## Conditions studied

- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** [ 18F]F-AraG PET

## Key facts

- **NCT ID:** NCT05096234
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-28
- **Primary completion:** 2022-05-09
- **Final completion:** 2023-10-09
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** loss of sponsor support
- **Last updated:** 2025-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05096234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05096234, "18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05096234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*